PROCORE TECHNOLOGIES, INC.·4

May 13, 8:13 PM ET

Courtemanche Craig F. Jr. 4

4 · PROCORE TECHNOLOGIES, INC. · Filed May 13, 2026

Research Summary

AI-generated summary of this filing

Updated

Procore (PCOR) Chairman Craig Courtemanche Exercises Options & Sells Shares

What Happened Craig F. Courtemanche Jr., Chairman of the Board of Procore Technologies (PCOR), exercised 56,122 option shares on May 11, 2026 at an exercise price of $2.42 per share (cost $135,815). The same day he sold all 56,122 shares in three open-market transactions, generating gross proceeds of approximately $2,865,484. The exercise and same‑day sales together indicate an immediate disposition of the acquired shares.

Key Details

  • Transaction date: May 11, 2026; Form 4 filed May 13, 2026 (timely filing).
  • Exercise: 56,122 shares @ $2.42 each — cost $135,815 (transaction code M).
  • Sales (all on May 11, 2026):
    • 24,286 shares, weighted avg $50.26 (range $49.74–$50.71) — proceeds $1,220,614. (F2)
    • 21,287 shares, weighted avg $51.16 (range $50.83–$51.75) — proceeds $1,089,043. (F3)
    • 10,549 shares, weighted avg $52.69 (range $52.21–$53.09) — proceeds $555,827. (F4)
  • Total gross proceeds from sales: ~$2,865,484; less exercise cost $135,815 → rough net proceeds ~$2,729,669.
  • Sales were made pursuant to a prearranged 10b5-1 plan dated Dec 9, 2025 (F1).
  • Additional footnotes: certain shares are held in family/irrevocable trusts (F5–F7); option vesting schedule noted (F8).
  • Shares owned after the transactions are not specified in the provided excerpt.

Context

  • The filing shows an option exercise (M) followed by immediate open‑market sales of the acquired shares — effectively a cashless exercise/sale to monetize vested options. Transaction codes and the matching quantities indicate the entire exercised position was sold the same day.
  • The sales were prearranged under a 10b5‑1 plan, which is a common mechanism for insiders to sell shares on a preset schedule and reduces the significance of short‑term timing. As with all insider sales, this is factual disclosure of a personal liquidity event and should not be taken alone as a signal about the company’s outlook.

Insider Transaction Report

Form 4
Period: 2026-05-11
Transactions
  • Exercise/Conversion

    Common Stock

    2026-05-11$2.42/sh+56,122$135,815983,702 total
  • Sale

    Common Stock

    [F1][F2]
    2026-05-11$50.26/sh24,286$1,220,614959,416 total
  • Sale

    Common Stock

    [F1][F3]
    2026-05-11$51.16/sh21,287$1,089,043938,129 total
  • Sale

    Common Stock

    [F1][F4]
    2026-05-11$52.69/sh10,549$555,827927,580 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F8]
    2026-05-11$2.42/sh56,122$135,815280,610 total
    Exercise: $2.42Exp: 2026-11-10Common Stock (56,122 underlying)
Holdings
  • Common Stock

    [F5]
    (indirect: See Footnote)
    2,692,461
  • Common Stock

    [F6]
    (indirect: See Footnote)
    1,155,480
  • Common Stock

    [F7]
    (indirect: See Footnote)
    527,349
  • Common Stock

    (indirect: By Spouse)
    23,736
Footnotes (8)
  • [F1]These shares sold pursuant to a 10b5-1 plan dated December 9, 2025.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $49.74 to $50.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $50.83 to $51.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $52.21 to $53.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]These shares are held by the Craig F. Courtemanche and Hillary Courtemanche Family Trust dated as of November 1, 2012.
  • [F6]These shares are held by the Courtemanche 2021 Irrevocable Trust UA DTD 6/10/2021.
  • [F7]These shares are held by The Courtemanche 2016 Irrevocable Trust.
  • [F8]The shares subject to the option vested in 60 equal monthly installments beginning on the one month anniversary of February 5, 2016, subject to continued service through each applicable vesting date.
Signature
/s/ Benjamin C. Singer, Attorney-in-Fact|2026-05-13

Documents

1 file
  • 4
    wk-form4_1778717609.xmlPrimary

    FORM 4